Pricing
  1. US-listed companies
  2. Ampio Pharmaceuticals, Inc.
  3. Financials
  4. Depreciation & amortization

Ampio Pharmaceuticals, Inc.【AMPE】

Market cap
$317.9K
P/E ratio
SummaryFinancials
Period EndDepreciation & amortization (Million USD)YoY (%)
Dec 31, 20230-88.36%
Dec 31, 20221-4.20%
Dec 31, 20211-7.05%
Dec 31, 20201-7.47%
Dec 31, 20191-0.73%
Dec 31, 20181+5.51%
Dec 31, 20171+0.00%
Dec 31, 20161+6.88%
Dec 31, 20151+158.78%
Dec 31, 20140+80.98%
Dec 31, 20130+131.19%
Dec 31, 20120+146.64%
Dec 31, 20110

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)